BVF as of June 30, 2019
Portfolio Holdings for BVF
BVF holds 56 positions in its portfolio as reported in the June 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Merus N V (MRUS) | 7.4 | $68M | 4.6M | 14.65 | |
| Cytokinetics Com New (CYTK) | 6.4 | $58M | 5.2M | 11.25 | |
| Array BioPharma | 6.0 | $55M | 1.2M | 46.33 | |
| Ac Immune Sa SHS (ACIU) | 6.0 | $55M | 9.8M | 5.55 | |
| Mirati Therapeutics | 5.9 | $54M | 527k | 103.00 | |
| Kura Oncology (KURA) | 4.7 | $43M | 2.2M | 19.69 | |
| Blueprint Medicines (BPMC) | 4.5 | $41M | 438k | 94.33 | |
| Infinity Pharmaceuticals (INFIQ) | 3.4 | $31M | 17M | 1.80 | |
| Arcus Biosciences Incorporated (RCUS) | 3.1 | $28M | 3.5M | 7.95 | |
| Molecular Templates | 3.0 | $27M | 3.3M | 8.35 | |
| Xoma Corp Del Com New (XOMA) | 2.9 | $27M | 1.8M | 14.86 | |
| Calithera Biosciences | 2.9 | $26M | 6.8M | 3.90 | |
| Replimune Group (REPL) | 2.8 | $25M | 1.7M | 14.66 | |
| Cytomx Therapeutics (CTMX) | 2.3 | $21M | 1.9M | 11.22 | |
| Concert Pharmaceuticals I equity | 2.1 | $20M | 1.6M | 12.00 | |
| Dicerna Pharmaceuticals | 2.1 | $19M | 1.2M | 15.75 | |
| Pieris Pharmaceuticals | 2.0 | $19M | 4.0M | 4.70 | |
| Five Prime Therapeutics | 2.0 | $18M | 3.0M | 6.03 | |
| Xenon Pharmaceuticals (XENE) | 1.9 | $17M | 1.7M | 9.86 | |
| Syndax Pharmaceuticals (SNDX) | 1.8 | $16M | 1.8M | 9.31 | |
| Ideaya Biosciences (IDYA) | 1.6 | $15M | 1.5M | 9.96 | |
| Galmed Pharmaceuticals SHS | 1.5 | $14M | 1.8M | 7.35 | |
| Chemocentryx | 1.4 | $13M | 1.4M | 9.30 | |
| Protagonist Therapeutics (PTGX) | 1.4 | $13M | 1.1M | 12.11 | |
| Akero Therapeutics (AKRO) | 1.4 | $12M | 648k | 19.15 | |
| Anaptysbio Inc Common (ANAB) | 1.3 | $12M | 205k | 56.42 | |
| Spero Therapeutics (SPRO) | 1.2 | $11M | 940k | 11.51 | |
| Corvus Pharmaceuticals (CRVS) | 1.1 | $10M | 2.8M | 3.74 | |
| Mersana Therapeutics | 1.1 | $10M | 2.5M | 4.05 | |
| Verastem | 1.0 | $9.6M | 6.3M | 1.51 | |
| Biolinerx Sponsored Ads | 1.0 | $9.5M | 26M | 0.36 | |
| Forward Pharma A/s Sponsored Adr | 1.0 | $8.7M | 8.5M | 1.03 | |
| X4 Pharmaceuticals | 1.0 | $8.7M | 581k | 15.00 | |
| Prevail Therapeutics Ord | 0.9 | $8.7M | 657k | 13.20 | |
| ArQule | 0.9 | $8.5M | 774k | 11.01 | |
| Genocea Biosciences Com New (GNCAQ) | 0.9 | $8.2M | 2.1M | 3.92 | |
| Eiger Biopharmaceuticals | 0.8 | $7.2M | 675k | 10.60 | |
| Ovid Therapeutics (OVID) | 0.7 | $6.6M | 3.6M | 1.85 | |
| Cti Biopharma Corp Com New | 0.7 | $6.0M | 6.9M | 0.86 | |
| Mei Pharma Com New | 0.6 | $5.6M | 2.2M | 2.50 | |
| Gamida Cell SHS | 0.6 | $5.1M | 1.0M | 5.08 | |
| Sunesis Pharmaceuticals Com Par | 0.5 | $4.9M | 6.8M | 0.73 | |
| Alpine Immune Sciences | 0.5 | $4.8M | 1.2M | 4.21 | |
| Spring Bk Pharmaceuticals In | 0.5 | $4.8M | 1.3M | 3.69 | |
| Erytech Pharma Sponsored Adr | 0.5 | $4.5M | 625k | 7.17 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.5 | $4.5M | 2.7M | 1.68 | |
| Essa Pharma Com New (EPIX) | 0.3 | $3.1M | 1.3M | 2.32 | |
| Surface Oncology | 0.3 | $2.9M | 1.0M | 2.82 | |
| Realm Therapeutics Sponsored Ads | 0.3 | $2.6M | 910k | 2.82 | |
| Regulus Therapeutics Com New | 0.3 | $2.5M | 2.0M | 1.25 | |
| Karyopharm Therapeutics | 0.2 | $2.1M | 355k | 5.99 | |
| Albireo Pharma | 0.2 | $2.1M | 66k | 32.24 | |
| Vical Com New | 0.2 | $1.6M | 1.8M | 0.85 | |
| Mereo Biopharma Group Ads (MREO) | 0.1 | $1.3M | 523k | 2.40 | |
| Contrafect | 0.1 | $968k | 1.9M | 0.51 | |
| Novus Therapeutics | 0.1 | $837k | 829k | 1.01 |
